It's likely you have seen or heard recent media reports about a proposed ban or cancellation of some implants and a 6 month suspension on other textured breast implants announced by the TGA or Therapeutic Goods Administration on 11 July 2019.
As of today's date 18 July there is currently no ban on textured implants, rather a notice of intent to manufacturers of textured breast implants that they have until the 24th of July to respond to the TGA proposal.
While still alarming and important that patients be well informed, the risk of BIA ALCL is still considered rare. As of February 2019 the current statistics are:
Studies have found a link between textured implants and the increased risk of developing Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA: ALCL). Here are some of the facts we do know:
BIA-ALCL is not breast cancer—it is a type of non-Hodgkin’s lymphoma (cancer of the immune system), that affects lymphocytes (immune cells), typically taking between 8-10 years to develop.
Individuals who have been implanted with textured breast implants at some point during their clinical history have a risk of developing BIA-ALCL. Other factors that may contribute to a diagnosis of BIA ALCL include:
Currently all breast implant manufacturers have until the 24 of July 2019 to submit their position for the continued use of textured breast implants. Until this time textured implants and tissue expanders are still available for use in Australia.
Where possible Dr Cheng uses smooth breast implants, however, in certain cases such as breast reconstruction and other situations textured implants may be more suitable to achieve an adequate result. In this instance Dr Cheng will discuss the options and risks and if necessary he will utilise the least textured breast implant option available.
You can find a comprehensive list of textured implants that may be included in this cancellation or suspension via the TGA website here.
If you don't have any signs or symptoms the TGA and other international experts are NOT advising removal of textured breast implants.
You can learn more about BIA ALCL assessment and treatment in a previous article here.
Typically the majority (85%) of BIA-ALCL cases have been found in a collection of fluid called a seroma. The fluid is commonly contained within the cavity between the breast implant itself and the scar tissue or capsule that forms around the breast implant. Occasionally a mass or tumour can grow which may indicate a more advanced case and which may require more extensive combinations of treatments.
More regular monitoring is suggested if you have polyurethane or textured implants. Further information about monitoring will be updated in the future once there is a recommended protocol. For now Dr Cheng would advise:
Other countries like France and Canada have not restricted minimally textured breast implants or tissue expanders.
It is best to make an appointment with your original surgeon (preferably a Specialist Plastic Surgeon) to discuss concerns relevant to your specific breast implants.
Dr Cheng and our team do see patients who have had their surgery elsewhere, however you do require all of your breast implant information and surgery notes. We recommend obtaining a referral from your GP and possibly an Ultrasound Scan prior to your appointment. Our friendly team can guide your through what is needed.
You can read more information about textured breast implants and BIA ALCL via the TGA Breast Implant Hub link here.
The Australian Society of Plastic Surgeons also have a patient information sheet you can read - you can read it here.
The Australian Society of Aesthetic Plastic Surgeons statement is here.
Or visit our Breast Augmentation and Implant page